Slope of the dose-response curve to inhaled histamine and methacholine and PC20 in subjects with symptoms of airway hyperexcitability and in normal subjects. 1985

J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin

Slopes of the dose-response curves to inhaled histamine or methacholine and PC20 were compared in 14 subjects with symptoms of bronchial hyperexcitability and in 10 normal subjects. Slopes were obtained by analyzing curves with 3 to 6 points by the least squares method. Only curves with satisfactory correlation coefficients corresponding to p values less than 0.05 were kept for analysis. Twelve of the 14 subjects with symptoms of bronchial hyperexcitability and 1 of the 10 normal subjects had slopes greater than 20 (percent change in FEV1/log histamine or methacholine concentration) (chi-square = 13.5, p less than 0.001). Eleven of the 14 subjects with symptoms of bronchial hyperexcitability and 1 of the 10 normal subjects had PC20 results less than or equal to 16 mg/ml (chi-square = 11.0, p less than 0.001). It is concluded that, using the method described in our study, slopes of the dose-response curve to inhaled histamine or methacholine are different in subjects with and without symptoms of bronchial hyperexcitability.

UI MeSH Term Description Entries
D008297 Male Males
D008450 Maximal Midexpiratory Flow Rate Measurement of rate of airflow over the middle half of a FORCED VITAL CAPACITY determination (from the 25 percent level to the 75 percent level). Common abbreviations are MMFR and FEF 25%-75%. Forced Expiratory Flow 025-075 Percent,FEF 25-75 Percent,Flow Rate, Maximal Midexpiratory,MMFR,25-75 Percent, FEF,25-75 Percents, FEF,FEF 25 75 Percent,FEF 25-75 Percents,Forced Expiratory Flow 025 075 Percent,Percent, FEF 25-75,Percents, FEF 25-75
D008688 Methacholine Compounds A group of compounds that are derivatives of beta-methylacetylcholine (methacholine). Compounds, Methacholine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing
D012130 Respiratory Hypersensitivity A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL. Airway Hyperresponsiveness,Hypersensitivity, Respiratory,Airway Hyper-Responsiveness,Airway Hyper Responsiveness,Airway Hyperresponsivenesses,Hyper-Responsiveness, Airway,Hyperresponsiveness, Airway,Respiratory Hypersensitivities
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory

Related Publications

J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
September 1993, Pulmonary pharmacology,
J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
September 1996, American journal of respiratory and critical care medicine,
J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
January 1983, Thorax,
J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
November 1989, The American review of respiratory disease,
J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
April 1988, Clinical pharmacology and therapeutics,
J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
November 1987, The American review of respiratory disease,
J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
June 1979, The American review of respiratory disease,
J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
July 1984, The American review of respiratory disease,
J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
July 1979, Journal of applied physiology: respiratory, environmental and exercise physiology,
J L Malo, and A Cartier, and L Pineau, and G Gagnon, and R R Martin
March 1990, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!